Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Sci. STKE, 4 March 2003
Vol. 2003, Issue 172, p. re4
[DOI: 10.1126/scisignal.1722003re4]

REVIEWS

Physiologic and Pathologic Events Mediated by Intramembranous and Juxtamembranous Proteolysis

Todd E. Golde* and Christopher B. Eckman

Mayo Clinic Jacksonville, Department of Neuroscience, 4500 San Pablo Road, Jacksonville, FL 32224, USA.

Abstract: Intramembranous proteolysis (IP) is a recently recognized mechanism for transmembrane signal transduction that involves proteolysis of transmembrane proteins within their membrane-spanning domains. Juxtamembranous proteolysis (JP) is similar, but proteolytic cleavage of a transmembrane protein occurs at a site close to, but not within, the transmembrane domain of the target protein. In both IP and JP, a soluble domain of a transmembrane protein is released from its membrane tether. This domain can then transmit a signal either locally or at some distance from the site of cleavage. In certain signaling pathways, JP and IP are linked. JP on one side of the membrane results in secondary IP, which then releases a signaling domain from the membrane. Whereas well-characterized proteases such as caspases, the proteasome, and metalloprotease disintegrins, have been implicated in JP, three families of multipass membrane proteases (MpMPs) have now been shown to carry out IP. Recent studies of events mediated by IP and JP indicate that they regulate key cellular signaling events including pathways involved in sterol regulation, cell fate selection, and growth regulation. Moreover, IP and JP have important roles in certain diseases such as Alzheimer's disease. Because some of the proteases mediating IP and JP can be selectivity inhibited, inhibitors targeting these proteases are likely to alter both physiologic and pathologic events triggered by IP and JP.

*Corresponding author: Telephone, 904-953-2538; fax, 904-953-7370; e-mail, tgolde{at}mayo.edu.

Citation: T. E. Golde, C. B. Eckman, Physiologic and Pathologic Events Mediated by Intramembranous and Juxtamembranous Proteolysis. Sci. STKE 2003, re4 (2003).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Proteases and Signaling.
S. Wilk (2005)
Sci. STKE 2005, tr15
   Abstract »    Full Text »    PDF »
Does the Road to Muscle Rejuvenation Go Through Notch?.
J. B. Miller and C. P. Emerson Jr. (2003)
Sci. Aging Knowl. Environ. 2003, pe34-34
   Abstract »    Full Text »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882